Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Xiaoyu ^a,b   Lao, Yuanzhi ^a,b   Xu, Naihan ^c   Xi, Zhichao ^a,b   Wu, Man ^a,b   Wang, Hua ^d   Li, Xiyi ^e   Tan, Hongsheng ^a,b   Sun, Menghong ^e   Xu, Hongxi ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery   (China)

^c TSINGHUA UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 18; KRT18 PROTEIN, HUMAN; OBLONGIFOLIN C; PLANT EXTRACT; SMALL INTERFERING RNA; TERPENE; TUBULIN;

ANIMAL; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; ESOPHAGEAL NEOPLASMS; GARCINIA; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; HUMAN; METABOLISM; MOUSE; NEOPLASM METASTASIS; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GARCINIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; KERATIN-18; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLANT EXTRACTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TERPENES; TUBULIN; WOUND HEALING;

EID: 84929353223     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10293     Document Type: Article

References (38)

1. Hiyama, T., Yoshihara, M., Tanaka, S. & Chayama, K. Genetic polymorphisms and esophageal cancer risk. Int. J. Cancer 121, 1643-1658 (2007).
2. Yang, C. S. Research on esophageal cancer in China: a review. Cancer Res. 40, 2633-2644 (1980).
3. Ekman, S. et al. Esophageal cancer: current and emerging therapy modalities. Expert Rev. Anticancer Ther. 8, 1433-1448 (2008).
4. Sun, Y., Yu, X. & Zhang, Y. Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review. World J. Surg. Oncol. 12, 165 (2014).
5. Huang, X., & Hollinger, F.B. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J. Viral Hepat 21, 153-162 (2014).
6. Zhang, Y., Shi, Z.L., Yang, X. & Yin, Z.F. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. World J. Gastroenterol 20, 142-147 (2014).
7. Qiao, M., Sheng, S. & Pardee, A. B. Metastasis and AKT activation. Cell Cycle 7, 2991-2996 (2008).
8. Sahai, E. Illuminating the metastatic process. Nat. Rev. Cancer 7, 737-749 (2007).
9. Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449-458 (2006).
10. Chen, R. S. et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Oncogene 28, 599-609 (2009).
11. Man, S., Gao, W., Wei, C. & Liu, C. Anticancer drugs from traditional toxic Chinese medicines. Phytother. Res. 26, 1449-1465 (2012).
12. Han, Q. B. & Xu, H. X. Caged Garcinia xanthones: development since 1937. Curr. Med. Chem. 16, 3775-3796 (2009).
13. Wang, X. & Chen, W. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anticancer. Agents. Med. Chem. 12, 994-1000 (2012).
14. Yi, T. et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res. 68, 1843-1850 (2008).
15. Fu, W. W., Tan, H. S. & Xu, H. X. Research progress of chemistry and anti-cancer activities of natural products from Chinese garcinia plants. Yao. Xue. Xue. Bao. 49, 166-174 (2014).
16. Feng, C. et al. A new anticancer compound, oblongifolin C, inhibits tumor growth and promotes apoptosis in HeLa cells through Bax activation. Int. J. Cancer. 131, 1445-1454 (2012).
17. Lao, Y. et al. The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation. Autophagy 10, 736-749(2014).
18. Huang, S. D. et al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol. Cancer 11, 51 (2012).
19. Han, Q. B. et al. Polyprenylated xanthones from Garcinia lancilimba showing apoptotic effects against HeLa-C3 cells. Chem. Biodivers 5, 2710-2717 (2008).
20. Huang, S. X, et al. Bioassay-guided isolation of xanthones and polycyclic prenylated acylphloroglucinols from Garcinia oblongifolia. J. Nat. Prod. 72, 130-135 (2009).
21. Xia, Z. X. et al. Bioassay-guided isolation of prenylated xanthones and polycyclic acylphloroglucinols from the leaves of Garcinia nujiangensis. J. Nat. Prod. 75, 1459-1464 (2012).
22. Lao, Y., Wang, X., Xu, N., Zhang, H. & Xu, H. Application of proteomics to determine the mechanism of action of traditional Chinese medicine remedies. J. Ethnopharmacol. 155, 1-8 (2014).
23. Liu, Y. H. et al. Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells. Biochem. Biophys. Res. Commun. 407, 575-580 (2011).
24. Weng, Y. R., Cui, Y. & Fang, J. Y. Biological functions of cytokeratin 18 in cancer. Mol Cancer Res. 10, 485-493 (2012).
25. Zhou, X. et al. MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer. PLoS One 9, e96718 (2014).
26. Chen, H. et al. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer. R. 69:9228-9235 (2009).
27. Bakin, A. V. et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810 (2000).
28. Yamashiro, Y. et al. Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma. Biochem. Biophys. Res. Commun. 399, 365-372 (2010).
29. Makino, T. et al. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus. Br. J. Cancer 10, 1298-1306 (2009).
30. Fillies, T.et al. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer 6, 10 (2006).
31. Fortier, A. M., Asselin, E. & Cadrin M. Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J. Biol. Chem. 288, 11555-11571 (2013).
32. Ha, S. A. et al. The prognostic potential of keratin 18 in breast cancer associated with tumor dedifferentiation, and the loss of estrogen and progesterone receptors. Cancer Biomark 10, 219-231 (2011).
33. Im, S. et al. Microtubule-Associated Protein Tau, alpha-Tubulin and betaIII-Tubulin Expression in Breast Cancer. Korean. J. Pathol. 47, 534-540 (2013).
34. Kingston, D. G. Tubulin-interactive natural products as anticancer agents. J. Nat. Prod. 72, 507-515 (2009).
35. Withana, N. P. et al. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res. 72, 1199-1209 (2012).
36. Gondi, C. S. & Rao, J. S. Cathepsin B as a cancer target. Expert Opin. Ther. Targets 17, 281-291 (2013).
37. Smilkstein, M. et al. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48, 1803-1806 (2004).
38. Kavallaris, M. et al. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res. 61, 5803-5809 (2001).